Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hoelzer

Showing results (131-140 of 415) with videos related to

Pageof 42
Sort By:
Onkologie|February 1, 1988
Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes--a phase-I/II trialA Ganser, B Völkers, J Greher, et al.
Blood Cells|January 1, 1988
In vitro and in vivo action of recombinant human GM-CSF (rhGM-CSF) in patients with myelodysplastic syndromesD Hoelzer, A Ganser, B Völkers, et al.
Leukemia & Lymphoma|June 1, 1994
Peroxidase expression in acute unclassified leukemias: ultrastructural studies in combination with immunophenotypingG Heil, E Gunsilius, D Hoelzer, et al.
Blut|April 1, 1984
Low-dose Ara-C in the treatment of acute leukemia. Cytotoxicity or differentiation induction?D Hoelzer, A Ganser, B Anger, et al.
Leukemia|July 1, 1991
Curing leukemiaR P Gale, J V Simone, D Hoelzer, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|April 1, 1994
The study and treatment of the myelodysplastic patientM A Sanz, J M Bennett, T Vallespí, et al.
European Journal of Clinical Investigation|June 1, 1972
The turnover of blast cells in peripheral blood after in vitro 3 H-cytidine labelling and retransfusion in human acute leukaemiaD Hoelzer, E B Harriss, T M Fliedner, et al.
Deutsche Medizinische Wochenschrift (1946)|May 28, 1993
[Pleomorphic T-cell lymphoma. The diagnostic problems, therapeutic possibilities and infection-induced complications]S Lob, L Bergmann, H Müller, et al.
Behring Institute Mitteilungen|August 1, 1988
Phase I/II study with GM-CSF in patients with myelodysplastic syndromesD Hoelzer, A Ganser, J Greher, et al.
International Journal of Hematology|August 7, 2007
Nonsecretory primary plasma cell leukemia with good response to thalidomide-based treatmentP Brück, S Mousset, A Bühme, et al.
Pageof 42

Showing results (131-140 of 415) with videos related to

Sort By:
Pageof 42
Onkologie|February 1, 1988
Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes--a phase-I/II trialA Ganser, B Völkers, J Greher, et al.
Blood Cells|January 1, 1988
In vitro and in vivo action of recombinant human GM-CSF (rhGM-CSF) in patients with myelodysplastic syndromesD Hoelzer, A Ganser, B Völkers, et al.
Leukemia & Lymphoma|June 1, 1994
Peroxidase expression in acute unclassified leukemias: ultrastructural studies in combination with immunophenotypingG Heil, E Gunsilius, D Hoelzer, et al.
Blut|April 1, 1984
Low-dose Ara-C in the treatment of acute leukemia. Cytotoxicity or differentiation induction?D Hoelzer, A Ganser, B Anger, et al.
Leukemia|July 1, 1991
Curing leukemiaR P Gale, J V Simone, D Hoelzer, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|April 1, 1994
The study and treatment of the myelodysplastic patientM A Sanz, J M Bennett, T Vallespí, et al.
European Journal of Clinical Investigation|June 1, 1972
The turnover of blast cells in peripheral blood after in vitro 3 H-cytidine labelling and retransfusion in human acute leukaemiaD Hoelzer, E B Harriss, T M Fliedner, et al.
Deutsche Medizinische Wochenschrift (1946)|May 28, 1993
[Pleomorphic T-cell lymphoma. The diagnostic problems, therapeutic possibilities and infection-induced complications]S Lob, L Bergmann, H Müller, et al.
Behring Institute Mitteilungen|August 1, 1988
Phase I/II study with GM-CSF in patients with myelodysplastic syndromesD Hoelzer, A Ganser, J Greher, et al.
International Journal of Hematology|August 7, 2007
Nonsecretory primary plasma cell leukemia with good response to thalidomide-based treatmentP Brück, S Mousset, A Bühme, et al.
Pageof 42